Venture capital is the lifeblood of up-and-coming biotechs. In order to interest investors and keep the money coming in, biotechs must have a strong vision, promising pipeline and a management team that can guide a company through the rigorous drug development process. For a look at which biotechs have gained the most attention this year, check out the five promising companies that raised the most money in the first half of 2007. List